-
1
-
-
0030939082
-
Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma
-
PID: 9118515, COI: 1:STN:280:ByiB3svgtFM%3D
-
Rossi GP, Sacchetto A, Pavan, et al.: Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma. Circulation 1997, 95:1471–1478.
-
(1997)
Circulation
, vol.95
, pp. 1471-1478
-
-
Rossi, G.P.1
Sacchetto, A.2
Pavan3
-
2
-
-
17144421237
-
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
-
PID: 15837256, COI: 1:CAS:528:DC%2BD2MXjtlagt70%3D
-
Milliez P, Girerd X, Plouin PF, et al.: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243–1245. DOI: 10.1016/j.jacc.2005.01.015
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1243-1245
-
-
Milliez, P.1
Girerd, X.2
Plouin, P.F.3
-
3
-
-
0029558829
-
Albuminuria in untreated patients with primary aldosteronism or essential hypertension
-
PID: 8903655, COI: 1:STN:280:ByiD2MbjtlA%3D
-
Halimi JM, Mimran A: Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995, 13:1801–1802.
-
(1995)
J Hypertens
, vol.13
, pp. 1801-1802
-
-
Halimi, J.M.1
Mimran, A.2
-
4
-
-
23944519498
-
Relative glomerular hyperfiltration in primary aldosteronism
-
PID: 15800124
-
Ribstein J, Du Cailar G, Fesler P, Mimran A: Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 2005, 16:1320–1325. DOI: 10.1681/ASN.2004100878
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1320-1325
-
-
Ribstein, J.1
Du Cailar, G.2
Fesler, P.3
Mimran, A.4
-
5
-
-
15944398341
-
Aldosterone as a cardiovascular risk factor
-
PID: 15808807, COI: 1:CAS:528:DC%2BD2MXivV2gs78%3D
-
Rossi G, Boscaro M, Ronconi V, Funder JW: Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab 2005, 16:104–107. DOI: 10.1016/j.tem.2005.02.010
-
(2005)
Trends Endocrinol Metab
, vol.16
, pp. 104-107
-
-
Rossi, G.1
Boscaro, M.2
Ronconi, V.3
Funder, J.W.4
-
6
-
-
0027174837
-
Evidence that primary hyperaldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers
-
PID: 8324912, COI: 1:CAS:528:DyaK3sXksVKmsLw%3D
-
Gordon RD, Ziesak MD, Tunny TJ, et al.: Evidence that primary hyperaldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993, 20:296–298.
-
(1993)
Clin Exp Pharmacol Physiol
, vol.20
, pp. 296-298
-
-
Gordon, R.D.1
Ziesak, M.D.2
Tunny, T.J.3
-
7
-
-
33748132658
-
A prospective study of the prevalence of primary aldosteronism in 1124 hypertensive patients
-
PID: 17161262, COI: 1:CAS:528:DC%2BD28Xht12ks7%2FK
-
Rossi GP, Bernini G, Caliumi C, et al.: A prospective study of the prevalence of primary aldosteronism in 1124 hypertensive patients. J Am Coll Cardiol 2006, 48:2293–2300. DOI: 10.1016/j.jacc.2006.07.059
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2293-2300
-
-
Rossi, G.P.1
Bernini, G.2
Caliumi, C.3
-
8
-
-
84884110141
-
A role of renal hemodynamics and arterial pressure in aldosterone “escape
-
Hall JE, Granger JP, Premen AJ: A role of renal hemodynamics and arterial pressure in aldosterone “escape.” Hypertension 1984, 6:1183–1192.
-
(1984)
Hypertension
, vol.6
, pp. 1183-1192
-
-
Hall, J.E.1
Granger, J.P.2
Premen, A.J.3
|